Jane Street’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.89M Buy
73,400
+11,200
+18% +$259K ﹤0.01% 5270
2026
Q1
$1.28M Buy
+62,200
New +$1.4M ﹤0.01% 5975
2025
Q4
Sell
-21,100
Closed -$525K 12110
2025
Q3
$525K Sell
21,100
-16,100
-43% -$346K ﹤0.01% 7758
2025
Q2
$856K Buy
37,200
+3,900
+12% +$90.3K ﹤0.01% 5911
2025
Q1
$748K Buy
33,300
+12,900
+63% +$300K ﹤0.01% 6111
2024
Q4
$399K Sell
20,400
-21,900
-52% -$434K ﹤0.01% 7240
2024
Q3
$770K Sell
42,300
-12,300
-23% -$235K ﹤0.01% 6410
2024
Q2
$949K Sell
54,600
-19,600
-26% -$347K ﹤0.01% 5874
2024
Q1
$1.45M Buy
74,200
+45,900
+162% +$969K ﹤0.01% 4710
2023
Q4
$652K Buy
28,300
+16,500
+140% +$369K ﹤0.01% 6309
2023
Q3
$271K Buy
11,800
+1,500
+15% +$38.1K ﹤0.01% 7209
2023
Q2
$269K Sell
10,300
-3,400
-25% -$89.8K ﹤0.01% 7288
2023
Q1
$378K Sell
13,700
-82,100
-86% -$2.17M ﹤0.01% 6812
2022
Q4
$2.18M Sell
95,800
-3,400
-3% -$94.6K ﹤0.01% 3741
2022
Q3
$3.38M Buy
+99,200
New +$3.67M ﹤0.01% 3254

Other funds holding PRVA

Jane Street's PRVA Position: Q2 2026 in Review

Jane Street sold out of Privia Health (PRVA) in Q2 2026, closing a stake of 68,227 shares — an estimated $1.58M sold.

Jane Street first reported a position in PRVA in Q3 2021 and held it in 14 quarters. The position peaked at $5.85M in Q1 2025. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Jane Street reported no remaining Privia Health position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 68,227 Privia Health shares in Q2 2026, an estimated $1.58M.
  • Jane Street first reported a position in Privia Health in Q3 2021 and held it in 14 quarters.
  • Jane Street's Privia Health position peaked at $5.85M in Q1 2025.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.